🇺🇸 FDA
Pipeline program

A clinical study of MK-5661 in healthy people (MK-5661-007)

MK-5661-007

Phase 1 other active

Quick answer

A clinical study of MK-5661 in healthy people (MK-5661-007) for Pain is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).

Program details

Company
Merck Sharp and Dohme
Indication
Pain
Phase
Phase 1
Modality
other
Status
active

Clinical trials